FIELD: child endocrinology. SUBSTANCE: level of neurospecific enolase in blood serum is determined to predict, when it is equal to 15.0 mg/ml or higher, development of severe form of diabetes mellitus by the end of the first disease year. EFFECT: improved prediction accuracy. 1 tbl, 4 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR TREATING INSULIN-DEPENDENT DIABETES MELLITUS (TYPE I) | 1997 |
|
RU2112541C1 |
METHOD FOR TREATMENT OF DIABETES MELLITUS AT CHILDREN | 1991 |
|
RU2018329C1 |
METHOD FOR DETERMINATION TYPE 1 DIABETES COMPENSATION FOR ADOLESCENTS | 2015 |
|
RU2613272C1 |
DIAGNOSTIC METHOD OF SEVERITY DEGREE OF DIABETIC ENCEPHALOPATHY WITH CHILDREN AND TEENAGERS | 2008 |
|
RU2368905C1 |
METHOD OF EARLY DETECTION OF DIABETICAL ENCEPHALOPATHY IN CHILDREN | 2008 |
|
RU2389027C2 |
METHOD OF PREDICTING THE DEVELOPMENT OF ANGIONEPHROPATHY IN DIABETES MELLITUS OF CHILDREN | 0 |
|
SU1500938A1 |
METHOD OF TREATMENT OR EARLY LIPID METABOLISM DISTURBANCE IN PATIENT WITH DIABETES OF THE 1-TYPE | 1992 |
|
RU2072860C1 |
METHOD OF CORRECTING INSULIN DOSAGE IN TREATING DIABETES MELLITUS | 1991 |
|
RU2009511C1 |
METHOD FOR PREDICTING OF SERIOUS COURSE OF DIABETIC PERIPHERIC POLINEUROPATHY AT CHILDREN AND TEENAGERS | 2007 |
|
RU2339955C1 |
METHOD FOR DETERMINING NECESSITY OF COMPENSATION OF TYPE 2 DIABETES MELLITUS (DM 2) | 2011 |
|
RU2474383C2 |
Authors
Dates
1999-09-20—Published
1997-05-27—Filed